NICE Scientific Advice events
Scientific Advice: A NICE perspective on pharmaceutical product development
A one-day seminar
Scientific advice meetings that involve both regulators and Health Technology Assessment (HTA) agencies are becoming increasingly common. This seminar is designed to provide an introduction to the general principles of HTA for non-experts. By understanding how the HTA and regulatory perspectives differ, participants will be able to maximise the benefit from scientific advice meetings and integrate HTA and health economic thinking into drug development plans at an early stage.
This one-day seminar will cover clinical and cost effectiveness methods and provide insights into effective planning for scientific advice meetings with HTA agencies. Considerations that influenced decision-making at NICE will be presented, using examples from past technology appraisals.
Who should attend?
- Anyone involved in scientific advice meetings for pharmaceutical products
- Members of drug development teams who are not HTA or health economics specialists
- Anyone with a general interest in understanding how HTA principles underpin market access decision making
Medical technology developers are advised to register for a NICE Scientific Advice seminar on 'Developing a Value Proposition: Devices & Diagnostics'.
What will you learn?
General principles/methods of HTA
- An understanding of the terminology
- Quality of life from an HTA perspective
- What is a QALY?
- What is an economic model?
- How the perspective of regulators and HTA agencies differs
- How to get the most out of scientific advice meetings
This page was last updated: 28 January 2013